English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

patients with Hashimoto's thyroiditis, who had very high titers of anti-thyroglobulin and anti-thyroid microsome antibodies. The specificity of this binding was analyzed. In contrast to serum of an insulin-treated diabetic patient which bound only 125Iinsulin, these sera bound various 125I-labelled peptides (insulin, C-peptide, gastrin, GH, prolactin and TSH) more than normal. The binding of 125I-insulin by serum of the insulin-treated patient was inhibited by insulin and iodinated insulin. On the other hand, 125I-insulin binding by sera of thyroiditis patients was decreased by the addition of iodinated insulin, iodinated albumin, thyroglobulin, MIT and DIT, but not by unlabelled insulin. Immunization of guinea pigs with thyroglobulin resulted in the production of antisera which bound 1251-insulin, and this binding was inhibited by iodinated peptides, MIT and DIT, but not by unlabelled insulin. Binding of 125I-insulin by sera of thyroiditis patients was not clearly demonstrated by gel filtration

Problems on the specificity of iodinated insulin binding by sera of patients with autoimmune thyroid disorders.